Hedera
Founded 2021 · 4 known investors
Hedera Dx provides hospital in-house laboratories with a full suite of NGS genomic tumor profiling solutions, including FFPE, ctDNA and RNA-only testing, plus software that generates clinical reports linking tumor sequences to approved therapies. It also supports real-world evidence generation for health systems, patients and drug development programs, with a stated focus on European hospital laboratories.
BiotechHealthtechMedical Devices
Investors · 4
In the news
Hedera (HBAR) Price Prediction 2026 2027 2028 - 2040changelly.com · Aug 2026
HBAR News: 40+ Banks Get Full Hedera Access as This Crypto Presale Pushes Past $2.34M Raisedopenpr.com · Aug 2026Frequently asked questions
- What does Hedera do?
- Hedera Dx provides hospital in-house laboratories with a full suite of NGS genomic tumor profiling solutions, including FFPE, ctDNA and RNA-only testing, plus software that generates clinical reports linking tumor sequences to approved therapies. It also supports real-world evidence generation for health systems, patients and drug development programs, with a stated focus on European hospital laboratories.
- Who are Hedera's investors?
- Hedera's investors include Air Street Capital, Bootstrap Europe, Vsquared Ventures, Inventure.